Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05934370
Other study ID # Pro00113089
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 20, 2023
Est. completion date August 2024

Study information

Verified date July 2023
Source Duke University
Contact Erin Frost, BS
Phone 919-613-3320
Email erin.frost@duke.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this open-label, single arm home intervention feasibility study is to improve quality of life for children ages 4-16 years with asthma. The main questions it aims to answer are: - How can Home-Based Environmental Interventions (HEI) improve home air-quality problems in the home? - How can HEI improve asthma outcomes in children? Participants will be receiving HEI and completing asthma surveys.


Description:

All participants will receive an Intervention Kit, which could help with reducing environmental exposures. Participants will be monitored closely with up to 2 clinic visits, 2 home visits and up to 4 phone call visits. During the home visits, a study team will ask questions about your home and asthma, conduct home assessments, and provide training on use of the home kit. Participants may benefit from participation in this study through Home-Based Environmental Interventions by improving home air-quality and asthma outcomes. Study duration is approximately 24-30 weeks with 8 weeks of intervention, which includes baseline interview, questionnaires, spirometry testing, and participants receiving an Intervention Kit.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 4 Years to 16 Years
Eligibility Inclusion Criteria: - Parent/legal guardian has provided informed consent (child has provided assent if needed) - 4-16 years of age with medical provider -diagnosed asthma - Evidence of recent poor asthma control, defined as either: 1. Asthma exacerbation requiring systemic steroids within 3 month of consent OR 2. ACQ6 > 1.0; or ACT/cACT = 19 during ambulatory visit within 3 months of consent - Family lives in one of the following Central NC counties: Alamance, Chatham, Durham, Franklin, Granville, Johnston, Lee, Orange, Person, Vance, or Wake counties - Family is not planning to move out of one of the approved counties accessible to Reinvestment Partners in the next 6 months Exclusion Criteria: - Lack of informed consent - Any major chronic illness that in the opinion of the Principal Investigator (PI) would interfere with participation in the intervention or completion of the study procedures - Inability to complete baseline measurements in a satisfactory manner according to the judgment of the research coordinator or PI - Parent/Caregiver unable to consent in English or Spanish - Sensitivity or allergy to silicone

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Home-Based Environmental Interventions (HEI)
Housing Specialist will conduct an environmental home assessment to identify asthma triggers. • The participant will receive the following Breath Easy at Home Kit Products: HEPA filtered upright vacuum cleaner HEPA-filtered air purifier Hypoallergenic latex free mattress and pillow covers Healthier household cleaners Non-toxic pest control devices for rodent control Safe products to locate and kill roaches.

Locations

Country Name City State
United States Duke University Health System Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Satisfaction A measure of satisfaction by distributing a satisfaction survey to each patient and caregiver Week 10
Primary Caregiver Satisfacation Survey A measure of satisfaction by distributing a satisfaction survey to each patient and caregiver Week 10
Primary Change in Air -Quality Index Air-quality index assessments will include: PM2.5, PM10, total VOC's, formaldehyde, carbon dioxide, Air Quality Index) in child's room and main living room using the Temtop M10, Temptop 2000C, and HEPA purifier air quality monitor. Week 4, Week 10
Primary Asthma healthcare utilization measured by number of clinic visits needed Determine ongoing need for healthcare utilization for participant's asthma Through study completion, an average of 24 weeks
Primary Asthma healthcare utilization measured by number of Emergency Department visits Determine ongoing need for healthcare utilization for participant's asthma Through study completion, an average of 24 weeks
Primary Asthma healthcare utilization measured by number of urgent care visits Determine ongoing need for healthcare utilization for participant's asthma Through study completion, an average of 24 weeks
Primary Asthma healthcare utilization measured by number of hospitalizations Determine ongoing need for healthcare utilization for participant's asthma Through study completion, an average of 24 weeks
Secondary Study Completion Study completion will be measured when 30 participants enroll and complete the intervention Through study completion, an average of 24 weeks
Secondary Change in Air Quality of Formaldehyde measured by a Temtop M10 The Temtop M10 will measure the amount of Formaldehyde in the home Week 8
Secondary Change in Air Quality of Particulate Matter (PM) measured by a Temtop M10 The Temtop M10 will measure the amount of Particulate Matter (PM) 2.5 in the home Week 8
Secondary Change in Air Quality of TVOC measured by a Temtop M10 The Temtop M10 will measure the amount of TVOC in the home Week 8
Secondary Change in Air Quality measured by a Temtop M10 The Temtop M10 will measure the air quality in the home Week 8
Secondary Air Quality changes of Particulate Matter (PM) 2.5 measured by a Temtop M2000c The Temtop M2000c will measure the Particulate Matter (PM)2.5 Week 8
Secondary Air Quality changes of particles measured by a Temtop M2000c The Temtop M2000c will measure the number of particles in the home Week 8
Secondary Air Quality changes of carbon dioxide measured by a Temtop M2000c The Temtop M2000c will measure the amount of carbon dioxide in the home Week 8
Secondary Air Quality changes of particulate matter (PM 10) measured by a Temtop M2000c The Temtop M2000c will measure the amount of particulate matter (PM 10) in the home Week 8
Secondary Air Quality changes measured by patient's air purifier The patient's air purifier will measure the air quality index in the home Week 8
Secondary Measurement of lung function Lung function will be measure by spirometry Week 10
Secondary Asthma Symptoms measured by the Asthma Control Questionnaire (ACQ 6) The Asthma Control Questionnaire (ACQ 6) is a 6 question self-report measure of asthma symptoms over the prior week. Items are rated on a sale ranging from 0 (never interferes with daily life) to 6 (interferes very severely with daily life). Higher scores indicate a worse outcome than lower scores. Week 10
Secondary Asthma symptoms measured by the Asthma Control Test (ACT or cACT) The Asthma Control Test (ACT or cACT) is a 5 question self-report measure of asthma symptoms over the prior four weeks. Items are rated on a scale ranging from 1 (All of the time) to 5 (none of the time). Lower scores indicate a worse outcome than higher scores. Week 10
Secondary Asthma symptoms measured by the Duke Asthma Score (DAS) The Duke Asthma Score (DAS) is a 6 question self-report measure of asthma symptoms over the prior month. Items are rated on a scale ranging from 0 (never) to 4 (every day). Higher scores indicate a worse outcome than lower scores. Week 10
See also
  Status Clinical Trial Phase
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Recruiting NCT05734261 - Forced Oscillations Technique During a Metacholine Test in Children N/A
Recruiting NCT06044051 - Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma N/A
Completed NCT04896502 - Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers N/A
Completed NCT03503812 - Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches N/A
Recruiting NCT06003569 - Reducing Asthma Attacks in Disadvantaged School Children With Asthma N/A
Not yet recruiting NCT05902702 - Isotonic Saline for Children With Bronchiolitis N/A
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT04388098 - Oral Health Status of Asthmatic Children
Terminated NCT03586544 - Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity Phase 4
Recruiting NCT04821908 - Consequences of COVID 19 Pandemic on Childhood Asthma
Not yet recruiting NCT03277170 - Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations Phase 2
Enrolling by invitation NCT06239844 - Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English N/A
Not yet recruiting NCT05974917 - Serious gaMes as Emerging E-health Interventions for Young People With neurologicaL or rEspiratory disoRders
Not yet recruiting NCT05997784 - Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
Recruiting NCT05366309 - Performance and Adherence in Children Using Spacers N/A
Completed NCT05684926 - COVID-19 Pandemic Asthma Child Telerehabilitation Yoga N/A
Recruiting NCT04166344 - A mHealth Intervention to Improve Symptom Control in Children and Adolescents With Difficult-to-control Asthma N/A
Completed NCT03907410 - The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial N/A
Completed NCT05576142 - Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma